LONDON & SEATTLE–(BUSINESS WIRE)–Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking treatments to improve vision in the aging eye, today announced that the U.S. Food and Drug Administration (F…
Category: News
Glaukos Announces US FDA Approval of NDA Supplement Allowing for Re-Administration of iDose® TR
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced that the U.S….
ESMO 2025: CheckMate 238 Update Reinforces Nivolumab Benefit
Dr Teresa Amaral discusses the 9-year update on CheckMate 238 presented at ESMO 2025. Medscape Oncology
Following Merger, Advancing Sight Network and Miracles In Sight Become Precision Ocular Network
BIRMINGHAM, Ala. & CLEMMONS, N.C.–(BUSINESS WIRE)–Advancing Sight Network and Miracles In Sight today announced Precision Ocular Network as the new name and brand of their combined organization, following the merger unveiled in November. The new iden…
Novaliq Receives FDA IND Clearance to Advance NOV05 in a Phase II Clinical Trial in Non-infectious Anterior Uveitis
HEIDELBERG, Germany & CAMBRIDGE, Mass.–(BUSINESS WIRE)– #FDA–Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on its unique water-free EyeSol® drug category, today announced that the U.S. Food and D…
Vision May Worsen Soon After Optic Nerve Stroke
Vision often worsens early in nonarteritic anterior ischemic optic neuropathy, and a past episode in the other eye predicts the decline but common cardiovascular factors do not, a study finds. Medscape Medical News
Eye Trauma in Ball Sports: Pickleball Injuries On the Rise
Analysis of a US database shows rising pickleball-related eye injuries, mainly in older adults, with falls and orbital fractures relatively more common in pickleball than in other ball sports. Medscape Medical News
What’s Good for the Heart Can Also Prevent Blindness
New research suggests that asymptomatic patients with significant risk factors for cardiovascular disease may also need to see an ophthalmologist. Medscape Medical News
UK Glaucoma Cases Set to Rise 60% by 2060, Study Warns
More than one million people in the UK may already have glaucoma, with cases projected to rise sharply by 2060, increasing demand for eye care services. Press Association
Artificial Iris Market Growth Forecast (2026-2032) Featuring Strategic Profiles of Leading Players Art Eyes, BrightOcular, Ophtec, REPER-NN, Spectrum Surgical, VEO Ophthalmics and More – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Artificial Iris Market – Global Forecast 2026-2032” has been added to ResearchAndMarkets.com’s offering. The Artificial Iris Market has shown significant growth, expanding from USD 17.71 million in 2024 to USD 19.31 millio…
FDA Makes Ianalumab Breakthrough for Sjögren Disease
Results from two clinical trials on ianalumab for Sjögren disease show favorable safety and adverse event outcomes, contributing to this designation. Medscape Medical News
FDA Makes Ianalumab a Breakthrough Therapy for Sjögren’s
Results from two clinical trials on ianalumab for Sjögren disease show favorable safety and adverse event outcomes, contributing to this designation. Medscape Medical News
As Private Equity Sells Out, Will Eye Practices Fare Better?
PE ownership of ophthalmology practices has reshaped physician opportunities and patient care. Will things change with publicly held companies buying them out? Medscape Medical News
Chicago Atlantic Provides $16.5 Million Term Loan to Ocular Science, Inc., a Leading Biotech Company Focused on Compounded Ophthalmic Products
CHICAGO–(BUSINESS WIRE)–Chicago Atlantic announced its role as sole arranger and administrative agent in the closing of a $16.5 million senior secured term loan for Ocular Science, Inc. (“Ocular Science”), an affiliate of OSRX, Inc. OSRX is a leading…
STAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, and Broadwood Partners, L.P. …
Study Links Eye Problems to Attention Disorders
Common eye conditions are linked to increased risks for incident attention-deficit/hyperactivity disorder, particularly in women and in the pediatric population, a retrospective study shows. Medscape Medical News
In Editorial, The New England Journal of Medicine Calls Science Corporation's PRIMA Implant "The First Treatment to Restore Vision" In Patients Suffering From Advanced Geographic Atrophy Due to Age-related Macular Degeneration
ALAMEDA, Calif.–(BUSINESS WIRE)–An editorial published today in The New England Journal of Medicine (NEJM) writes that Science Corporation’s PRIMA implant is the first treatment in clinical trials to successfully restore functional vision to certain …
Advice on Recognizing and Managing Sjӧgren Disease
Dr Nancy Carteron urges clinicians to learn to recognize how Sjӧgren disease could be hiding in plain sight and why early care is more essential than ever. Medscape
When Eye Problems Signal a Wider Immune Issue and Vice Versa
Patients with immune-mediated diseases face a high risk for incident uveitis, and those with uveitis face a high risk of developing or already having an immune-mediated disease, a recent study shows. Medscape Medical News
Eyeing Topical Options for Night Driving Problems
Impaired night vision affects 25 million Americans. Studies suggest topically reducing pupil size might help, especially for halo or starburst effects after refractive surgery. Medscape Medical News